Pharma & Biotech
You will receive alerts when there are new announcements on Nuformix PLC
Only registered members can use this feature.
Nuformix is a pharmaceutical development company focused on unlocking the therapeutic potential and value of known drugs to develop new novel medicines to provide enhanced benefit with lead programmes in fibrosis and oncology supportive care .
Oxilio took out an option on NXP001 in oncology in September
© Proactive Investors 2020.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.